Live News EQUITY FLASH L impact Oct 27, 2026, 12:19 PM UTC Polyrizon Completes Enrollment of 120 Patients in US NASARIX Allergy Study Polyrizon completed enrollment of 120 patients in its US NASARIX allergy study. PLRZ SquawkNews Desk